298 related articles for article (PubMed ID: 32333051)
1. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy.
Meregalli C; Fumagalli G; Alberti P; Canta A; Carozzi VA; Chiorazzi A; Monza L; Pozzi E; Sandelius Å; Blennow K; Zetterberg H; Marmiroli P; Cavaletti G
Exp Neurol; 2018 Sep; 307():129-132. PubMed ID: 29908147
[TBL] [Abstract][Full Text] [Related]
3. Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity.
Meregalli C; Monza L; Chiorazzi A; Scali C; Guarnieri C; Fumagalli G; Alberti P; Pozzi E; Canta A; Ballarini E; Rodriguez-Menendez V; Oggioni N; Cavaletti G; Marmiroli P
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494384
[TBL] [Abstract][Full Text] [Related]
4. Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients.
Karteri S; Bruna J; Argyriou AA; Mariotto S; Velasco R; Alemany M; Kalofonou F; Alberti P; Dinoto A; Velissaris D; Stradella A; Cavaletti G; Ferrari S; Kalofonos HP
J Peripher Nerv Syst; 2022 Jun; 27(2):166-174. PubMed ID: 35384143
[TBL] [Abstract][Full Text] [Related]
5. Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: The role of nerve excitability testing.
Chiorazzi A; Canta A; Carozzi VA; Meregalli C; Pozzi E; Ballarini E; Rodriguez-Menendez V; Marmiroli P; Cavaletti G; Alberti P
J Peripher Nerv Syst; 2024 Mar; 29(1):47-57. PubMed ID: 38009865
[TBL] [Abstract][Full Text] [Related]
6. Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer.
Mortensen C; Steffensen KD; Simonsen E; Herskind K; Madsen JS; Olsen DA; Iversen DB; Bergmann TK; Pottegård A; Stage TB
Pain; 2023 Jul; 164(7):1502-1511. PubMed ID: 36508173
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.
Huehnchen P; Schinke C; Bangemann N; Dordevic AD; Kern J; Maierhof SK; Hew L; Nolte L; Körtvelyessy P; Göpfert JC; Ruprecht K; Somps CJ; Blohmer JU; Sehouli J; Endres M; Boehmerle W
JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35133982
[TBL] [Abstract][Full Text] [Related]
8. Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy.
Chine VB; Au NPB; Kumar G; Ma CHE
Mol Neurobiol; 2019 May; 56(5):3244-3259. PubMed ID: 30117103
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity.
Velasco R; Argyriou AA; Marco C; Mariotto S; Stradella A; Hernández J; Pernas S; Ferrari S; Bruna J
J Neurol; 2023 Jan; 270(1):531-537. PubMed ID: 36094631
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
12. Blood Neurofilament Light Chain as a Potential Biomarker for Central and Peripheral Nervous Toxicity in Rats.
Sano T; Masuda Y; Yasuno H; Shinozawa T; Watanabe T; Kakehi M
Toxicol Sci; 2021 Dec; 185(1):10-18. PubMed ID: 34677616
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
[TBL] [Abstract][Full Text] [Related]
14. Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Keddie S; Smyth D; Keh RYS; Chou MKL; Grant D; Surana S; Heslegrave A; Zetterberg H; Wieske L; Michael M; Eftimov F; Bellanti R; Rinaldi S; Hart MS; Petzold A; Lunn MP
Brain; 2023 Nov; 146(11):4562-4573. PubMed ID: 37435933
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats.
Meregalli C; Marjanovic I; Scali C; Monza L; Spinoni N; Galliani C; Brivio R; Chiorazzi A; Ballarini E; Rodriguez-Menendez V; Carozzi VA; Alberti P; Fumagalli G; Pozzi E; Canta A; Quartu M; Briani C; Oggioni N; Marmiroli P; Cavaletti G
J Neuroinflammation; 2018 Aug; 15(1):232. PubMed ID: 30131066
[TBL] [Abstract][Full Text] [Related]
16. Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome.
Körtvelyessy P; Kuhle J; Düzel E; Vielhaber S; Schmidt C; Heinius A; Leypoldt F; Schraven B; Reinhold D; Leppert D; Goihl A
Ann Clin Transl Neurol; 2020 Nov; 7(11):2213-2220. PubMed ID: 33030817
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models.
Carozzi VA; Chiorazzi A; Canta A; Meregalli C; Oggioni N; Cavaletti G; Marmiroli P
Exp Neurol; 2015 Feb; 264():92-102. PubMed ID: 25450467
[TBL] [Abstract][Full Text] [Related]
18. Effect of age on metabolomic changes in a model of paclitaxel-induced peripheral neurotoxicity.
Bonomo R; Canta A; Chiorazzi A; Carozzi VA; Meregalli C; Pozzi E; Alberti P; Frampas CF; Van der Veen DR; Marmiroli P; Skene DJ; Cavaletti G
J Peripher Nerv Syst; 2024 Mar; 29(1):58-71. PubMed ID: 38126610
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity.
Theil D; Kuhle J; Brees D; Tritto E; Pognan F; Frieauff W; Penraat K; Meseck E; Valdez R; Hartmann A
Toxicol Pathol; 2023 Apr; 51(3):135-147. PubMed ID: 37439009
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability.
Kalm M; Boström M; Sandelius Å; Eriksson Y; Ek CJ; Blennow K; Björk-Eriksson T; Zetterberg H
Brain Res; 2017 Aug; 1668():12-19. PubMed ID: 28522263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
